Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

OSUR

Orasure Technologies Inc.

Nov 30 • 12:47PM ET

7.32

Dollar change +0.05
Percentage change 0.76	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	11.01	EPS (ttm)	0.67	Insider Own	4.52%	Shs Outstand	72.73M	Perf Week	1.03%
Market Cap	538.24M	Forward P/E	-	EPS next Y	-0.25	Insider Trans	3.05%	Shs Float	70.16M	Perf Month	41.96%
Income	49.14M	PEG	0.55	EPS next Q	0.10	Inst Own	91.71%	Short Float / Ratio	4.68% / 6.21	Perf Quarter	13.39%
Sales	452.67M	P/S	1.19	EPS this Y	317.33%	Inst Trans	-4.39%	Short Interest	3.28M	Perf Half Y	32.46%
Book/sh	5.51	P/B	1.33	EPS next Y	-146.47%	ROA	11.04%	Target Price	6.00	Perf Year	51.66%
Cash/sh	3.06	P/C	2.39	EPS next 5Y	20.00%	ROE	13.16%	52W Range	4.38 - 7.82	Perf YTD	51.97%
Dividend	-	P/FCF	7.08	EPS past 5Y	-	ROI	11.79%	52W High	-6.33%	Beta	0.21
Dividend %	-	Quick Ratio	7.26	Sales past 5Y	21.36%	Gross Margin	41.12%	52W Low	67.43%	ATR	0.23
Employees	840	Current Ratio	8.71	Sales Q/Q	-23.42%	Oper. Margin	10.93%	RSI (14)	77.10	Volatility	2.35% 4.06%
Optionable	Yes	Debt/Eq	0.04	EPS Q/Q	107.32%	Profit Margin	10.86%	Rel Volume	0.45	Prev Close	7.27
Shortable	Yes	LT Debt/Eq	0.03	Earnings	Nov 07 AMC	Payout	-	Avg Volume	528.88K	Price	7.32
Recom	2.67	SMA20	11.59%	SMA50	22.69%	SMA200	24.30%	Volume	124,743	Change	0.76%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-03-23	Resumed	Evercore ISI	In-line	$5
Sep-22-21	Downgrade	Raymond James	Outperform → Mkt Perform
Aug-21-20	Initiated	Evercore ISI	Outperform	$22
Aug-10-20	Initiated	JP Morgan	Neutral	$18
Aug-10-20	Initiated	Citigroup	Buy	$18
Aug-07-20	Upgrade	Raymond James	Mkt Perform → Outperform	$16
Jun-25-20	Initiated	Lake Street	Buy	$19
Apr-21-20	Resumed	Stephens	Equal-Weight	$14
Oct-23-18	Resumed	Raymond James	Mkt Perform
Jul-16-18	Downgrade	Stephens	Overweight → Equal-Weight
Nov-02-17	Downgrade	Jefferies	Buy → Hold
Feb-09-17	Upgrade	Raymond James	Mkt Perform → Outperform
Jun-13-16	Downgrade	Raymond James	Outperform → Mkt Perform
Nov-05-15	Reiterated	Mizuho	Buy	$12 → $8
May-07-15	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jan-23-15	Reiterated	Mizuho	Buy	$10 → $12
Jun-12-14	Reiterated	Canaccord Genuity	Buy	$10 → $11
Jun-11-14	Reiterated	Mizuho	Buy	$9 → $10
Dec-21-12	Initiated	Mizuho	Buy	$9
Aug-08-12	Upgrade	Barrington Research	Mkt Perform → Outperform	$12.50

Show Previous Ratings

Nov-27-23 09:55AM	After Golden Cross, OraSure Technologies (OSUR)'s Technical Outlook is Bright (Zacks)
Nov-13-23 04:15PM	OraSure to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-09-23 11:12AM	7 Healthcare Stocks That Are Poised to Become the Next Unicorns (InvestorPlace)
Nov-08-23 12:14PM	OraSure Technologies, Inc. (NASDAQ:OSUR) Q3 2023 Earnings Call Transcript (Insider Monkey)
08:40AM	Q3 2023 OraSure Technologies Inc Earnings Call (Thomson Reuters StreetEvents)
06:50PM	Loading…
Nov-07-23 06:50PM	OraSure Technologies (OSUR) Tops Q3 Earnings and Revenue Estimates (Zacks)
05:47PM	OraSure: Q3 Earnings Snapshot (Associated Press Finance)
04:59PM	OraSure Technologies Inc (OSUR) Q3 Earnings: Core Business Grows Amidst Decline in COVID-19 Revenue (GuruFocus.com)
04:05PM	OraSure Reports Q3 23 Revenue of $89.2 Million; Core Revenue Grows 7% Year-over-Year (GlobeNewswire)
Oct-23-23 04:05PM	OraSure to Announce Third Quarter 2023 Financial Results and Host Earnings Call on November 7th (GlobeNewswire)
Aug-09-23 06:02AM	Industry Analysts Just Made A Sizeable Upgrade To Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Forecasts (Simply Wall St.)
Aug-05-23 08:52AM	OraSure Technologies, Inc.'s (NASDAQ:OSUR) Intrinsic Value Is Potentially 57% Above Its Share Price (Simply Wall St.)
Aug-04-23 11:45AM	Q2 2023 OraSure Technologies Inc Earnings Call (Thomson Reuters StreetEvents) +32.29%
Aug-03-23 05:55PM	OraSure Technologies (OSUR) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:58PM	OraSure: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Loading…
04:05PM	OraSure Reports Q2 23 Revenue of $85.4 Million; Core Revenue Grows 3% Year-over-Year (GlobeNewswire)
Jul-20-23 04:05PM	OraSure to Announce Second Quarter 2023 Financial Results and Host Earnings Call on August 3rd (GlobeNewswire)
07:05AM	OraSure Technologies Elects Robert McMahon to the Board of Directors (GlobeNewswire)
Jun-29-23 07:07AM	OraSure Technologies' (NASDAQ:OSUR) investors will be pleased with their favorable 82% return over the last year (Simply Wall St.)
Jun-21-23 08:00PM	OSUR: What does Argus have to say about OSUR? (Argus Research)
Jun-13-23 04:05PM	Study Concludes Self-Sampling Using Colli-Pee® Device for HPV Screening Is Both Cost Effective and Could Improve Patient Access (GlobeNewswire)
Jun-08-23 11:03AM	OraSure Technologies (NASDAQ:OSUR) Has More To Do To Multiply In Value Going Forward (Simply Wall St.)
Jun-01-23 06:29AM	Daily Vickers Top Buyers & Sellers for 06/01/2023 (Argus Research) +9.94%
May-16-23 06:08AM	Time To Worry? Analysts Just Downgraded Their OraSure Technologies, Inc. (NASDAQ:OSUR) Outlook (Simply Wall St.)
May-12-23 07:12AM	Can Mixed Fundamentals Have A Negative Impact on OraSure Technologies, Inc. (NASDAQ:OSUR) Current Share Price Momentum? (Simply Wall St.) -18.67%
May-11-23 11:03AM	Q1 2023 OraSure Technologies Inc Earnings Call (Thomson Reuters StreetEvents)
May-10-23 05:35PM	OraSure Technologies (OSUR) Q1 Earnings and Revenues Beat Estimates (Zacks)
04:34PM	OraSure: Q1 Earnings Snapshot (AP Finance)
04:05PM	OraSure Reports 1Q23 Record Revenue of $155.0 Million; Announces New Collaborations as Company Increasingly Focuses on Core Growth (GlobeNewswire)
May-03-23 07:05AM	2023 First Quarter Earnings Conference Call Wednesday, May 10, 2023, 5:00 p.m. ET (GlobeNewswire)
08:00PM	Loading…
Apr-26-23 08:00PM	OSUR: What does Argus have to say about OSUR? (Argus Research)
Apr-21-23 09:40AM	Is OraSure Technologies (OSUR) Outperforming Other Medical Stocks This Year? (Zacks)
Apr-05-23 08:38AM	OraSure (OSUR) Stock Jumps 9.3%: Will It Continue to Soar? (Zacks)
Mar-29-23 07:30AM	We're Hopeful That OraSure Technologies (NASDAQ:OSUR) Will Use Its Cash Wisely (Simply Wall St.)
Mar-21-23 07:22AM	Zacks.com featured highlights include OraSure Technologies, Compania de Minas Buenaventura SAA and Vipshop (Zacks)
Mar-20-23 07:20AM	3 Low-Beta Stocks to Buy to Combat the Volatile Market (Zacks)
Mar-08-23 11:53AM	OraSure Technologies, Inc. (NASDAQ:OSUR) is a favorite amongst institutional investors who own 79% (Simply Wall St.)
Feb-23-23 12:20PM	Surging Earnings Estimates Signal Upside for OraSure (OSUR) Stock (Zacks)
Feb-16-23 04:38PM	OraSure Technologies, Inc. (NASDAQ:OSUR) Q4 2022 Earnings Call Transcript (Insider Monkey)
05:41AM	OraSure Technologies Full Year 2022 Earnings: Beats Expectations (Simply Wall St.)
Feb-15-23 03:48PM	Why OraSure Technologies Stock Is Jumping Today (Motley Fool) +12.17%
Feb-14-23 06:05PM	OraSure Technologies (OSUR) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
04:05PM	OraSure Reports 4Q22 Record Revenue of $123.1 Million Growing 94% Year-Over-Year; Positions for Longer-Term Growth and Profitability (GlobeNewswire)
Feb-07-23 07:05AM	2022 Fourth Quarter Earnings Conference Call Tuesday, February 14, 2023, 5:00 p.m. ET (GlobeNewswire)
06:37AM	Quite a few insiders invested in OraSure Technologies, Inc. (NASDAQ:OSUR) last year which is positive news for shareholders (Simply Wall St.)
Dec-21-22 07:52AM	Investors in OraSure Technologies (NASDAQ:OSUR) have unfortunately lost 74% over the last five years (Simply Wall St.)
Dec-01-22 07:05AM	OraSure Technologies Continues its Dedication to Ending the HIV Epidemic (GlobeNewswire)
Nov-14-22 07:05AM	OraSure Technologies to Present at Stephens Annual Investment Conference (GlobeNewswire)
Nov-08-22 06:05PM	OraSure Technologies (OSUR) Q3 Earnings and Revenues Top Estimates (Zacks)
04:05PM	OraSure Reports 3Q22 Record Revenue of $116.5 Million Growing 116% Year-Over-Year (GlobeNewswire)
Nov-03-22 09:15AM	OraSure Technologies Receives General Clearance for its ORAcollect®Dx Device for Over-the Counter (OTC) Use from the U.S. Food and Drug Administration (FDA) (GlobeNewswire)
Nov-02-22 07:05AM	InteliSwab® COVID-19 Rapid Test Now Available in Amazons Online Store (GlobeNewswire)
Nov-01-22 07:05AM	2022 Third Quarter Earnings Conference Call Tuesday, November 8, 2022, 5:00 p.m. ET (GlobeNewswire)
Oct-07-22 09:14AM	3 Penny Stocks That Are Too Cheap to Ignore (InvestorPlace)
Oct-01-22 10:30AM	Is OraSure Technologies (NASDAQ:OSUR) In A Good Position To Deliver On Growth Plans? (Simply Wall St.)
Sep-28-22 10:28AM	OraSure Secures BARDA Funding For Next-Gen Ebola Diagnostic Test (Benzinga) +9.84%
07:05AM	OraSure Technologies Receives $8.6 Million BARDA Contract to Develop 2nd Generation Ebola Test (GlobeNewswire)
Sep-20-22 04:05PM	OraSure Wins Contract to Supply Together Take Me Home, HIV Self-Testing Initiative Sponsored by the Centers for Disease Control and Prevention (GlobeNewswire)
Sep-14-22 07:05AM	OraSure Partners with Mars Petcare in One of the Largest Ever Microbiome Studies to Evaluate Pet Health (GlobeNewswire)
Aug-31-22 06:29AM	Independent Director Ronny Lancaster Just Bought 91% More Shares In OraSure Technologies, Inc. (NASDAQ:OSUR) (Simply Wall St.)
Aug-14-22 08:28AM	Analysts Just Published A Bright New Outlook For OraSure Technologies, Inc.'s (NASDAQ:OSUR) (Simply Wall St.)
Aug-09-22 07:25PM	OraSure Technologies (OSUR) Reports Break-Even Earnings for Q2 (Zacks)
04:05PM	OraSure Reports 2Q22 Record Revenue of $80.2 Million Growing 39% Year-Over-Year (GlobeNewswire)
Aug-02-22 07:05AM	OraSure Technologies to Hold 2022 Second Quarter Earnings Conference Call Tuesday, August 9, 2022, 5:00 p.m. ET (GlobeNewswire)
Jul-28-22 07:05AM	OraSures Ongoing Commitment to End the Hepatitis C Epidemic Heats Up at the Racetrack (GlobeNewswire)
Jul-14-22 08:42AM	OraSure Technologies (NASDAQ:OSUR) shareholders have endured a 84% loss from investing in the stock five years ago (Simply Wall St.)
07:05AM	OraSure Technologies Launches New Product for Microbiome Researchers to Study DNA and RNA (GlobeNewswire)
Jun-14-22 08:31AM	Does This Valuation Of OraSure Technologies, Inc. (NASDAQ:OSUR) Imply Investors Are Overpaying? (Simply Wall St.)
Jun-08-22 04:05PM	OraSure Technologies Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire) -9.01%
May-25-22 07:05AM	InteliSwab® COVID-19 Rapid Test Selected by Federal Government for Nationwide School Testing (GlobeNewswire)
May-23-22 04:05PM	Carrie Eglinton Manner Appointed Chief Executive Officer of OraSure (GlobeNewswire)
May-17-22 07:05AM	InteliSwab® COVID-19 Rapid Test Validated to Detect the Omicron BA.2, BA.2.12.1, BA.3 and BA.5 Subvariants (GlobeNewswire)
May-10-22 06:55PM	OraSure Technologies (OSUR) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -6.56%
04:05PM	OraSure Reports 1Q22 Record Revenue of $67.7 Million; +16% Year-Over-Year With 21% Growth in Non-COVID Revenue (GlobeNewswire)
May-04-22 06:45PM	PetIQ (PETQ) Q1 Earnings and Revenues Top Estimates (Zacks)
May-03-22 04:05PM	OraSure Technologies, Inc. 2022 First Quarter Earnings Conference Call Tuesday, May 10, 2022, 5:00 p.m. ET (GlobeNewswire)
Apr-24-22 10:21AM	We're Not Very Worried About OraSure Technologies' (NASDAQ:OSUR) Cash Burn Rate (Simply Wall St.)
Apr-07-22 07:05AM	OraSure Technologies Subsidiary DNA Genotek Launches the First Device with De Novo Authorization from the FDA for the Preservation and Stabilization of Microbiome Samples (GlobeNewswire)
Mar-31-22 07:05AM	OraSure Technologies Subsidiary Diversigen Launches Metatranscriptomic Sequencing and Analysis Services for Gut Microbiome Samples (GlobeNewswire)
Mar-22-22 04:05PM	OraSure Director Nancy Gagliano Selected to Serve as Interim Chief Executive Officer; Brings Extensive Diagnostics and Healthcare Leadership Experience to Role (GlobeNewswire)
Feb-23-22 04:05PM	OraSure Technologies Reports 4Q21 Revenue of $63.6 Million; InteliSwab® Production Scales Up (GlobeNewswire)
Feb-16-22 04:05PM	OraSure Technologies, Inc. 2021 Fourth Quarter Earnings Conference Call Wednesday, February 23, 2022, 5:00 p.m. ET (GlobeNewswire)
Jan-31-22 07:54AM	OraSure said its rapid COVID-19 tests can now be used in children (MarketWatch)
07:05AM	InteliSwab® COVID-19 Rapid Tests Receive U.S. FDA Authorization for Pediatric Use and Company Launches New InteliSwab® Connect Reporting App (GlobeNewswire)
Jan-25-22 07:05AM	OraSure Technologies, Inc. Expands HIV Oral Swab In-home Test into Europe (GlobeNewswire)
Jan-24-22 10:04AM	OraSure Technologies (NASDAQ:OSUR) shareholders have endured a 36% loss from investing in the stock a year ago (Simply Wall St.)
Jan-19-22 05:38PM	Peoples Financial Services Corp. Buys Danaher Corp, Goldman Sachs Group Inc, Thermo Fisher ... (GuruFocus.com)
Jan-13-22 04:05PM	InteliSwab® COVID-19 Rapid Tests Detect Omicron at Same Level as Other Variants (GlobeNewswire)
Jan-06-22 11:09AM	Stephen Tang stepping down as OraSure president and CEO (American City Business Journals)
Jan-05-22 04:24PM	COVID-19 home tests: Where to find these in-demand products (Yahoo Finance)
07:05AM	OraSure Technologies Announces Actions to Enhance Stockholder Value (GlobeNewswire)
Dec-14-21 07:05AM	OraSure Technologies Announces 2022 Annual Meeting Date (GlobeNewswire)
Nov-30-21 07:05AM	OraSure Technologies Remains Committed to the Global Fight Against HIV 40 Years After the Discovery of the HIV Virus (GlobeNewswire)
Nov-19-21 07:05AM	OraSure Technologies to Present at Upcoming Investor Conferences (GlobeNewswire)
Nov-11-21 09:34AM	OraSure Technologies (NASDAQ:OSUR) Is Reinvesting At Lower Rates Of Return (Simply Wall St.)
Nov-09-21 07:05AM	OraSure Technologies Announces the Retirement of Jack E. Jerrett and Appointment of Agnieszka M. Gallagher as General Counsel, Chief Compliance Officer and Secretary (GlobeNewswire)
Nov-08-21 07:05AM	OraSure Technologies Appoints Two New Members to the Board of Directors (GlobeNewswire)
Nov-04-21 12:31AM	Orasure Technologies Inc (OSUR) Q3 2021 Earnings Call Transcript (Motley Fool) -7.36%
Nov-03-21 07:15PM	OraSure Technologies (OSUR) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	OraSure Technologies Reports 3Q21 Revenue of $53.9 Million, Signs Three Major U.S. Government Contracts Positioning the Company for Significant InteliSwab Growth in FY22 (GlobeNewswire)

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offer oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Anthony Michele Marie	SVP Finance & CAO	Aug 15	Option Exercise	5.71	1,758	10,038	87,946	Aug 17 04:27 PM
Anthony Michele Marie	SVP Finance & CAO	Aug 15	Sale	6.50	1,758	11,427	86,188	Aug 17 04:27 PM
McGrath Kenneth J	Chief Financial Officer	May 30	Buy	4.93	100,000	492,810	285,512	May 31 04:14 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

OSUR

Orasure Technologies Inc.

Upgrade your FINVIZ experience